Looking Into Alzheimer Research


Alzheimers disease affects millions of people world wide, and their loved ones. Alzheimer disease is a progressive brain disorder that has devastating results on patients. The disease was first discussed in 1906 at a medical meeting in Germany. Dr. Alois Alzheimer reported on a strange case that he had involving a 51 year old woman. This womans symptoms did not seem to match any in the realm of psychology. She had rapid memory loss, confusion, disorientation and was suspicious of her own family and staff members at the hospital.

When the woman died, Dr. Alzheimer performed an autopsy of her brain and was shocked to find the deterioration that had occurred. He documented what he had discovered, and the disease was named after him.

Today Alzheimer research is conducted around the world, in hopes of discovering a way to prevent, or treat this disease. Alzheimer research is opening the door to a variety of new information regarding this disease.

What Alzheimer Research Tells Us

Alzheimer research is conducted at many different clinics around the world. Yearly, Alzheimer researchers get together to discuss their findings, and make connections about what they have discovered.

Alzheimer research is leading to some interesting thoughts about Alzheimers. One theory that has been to spring forth is a connection between Alzheimers and insulin resistant Type 2 Diabetes. There seems to be some Alzheimer research to support a connection between a persons chances of getting Alzheimers and if they have Diabetes.

Another interesting discovery was that changes in the eye lens may indicate Alzheimers. The eye was exposed to a rapid non-invasive laser, and changes were noted. These were thought to correlate to the build-up on the brain of beta-amyloid. This is a plaque like substance that is found on the brains of Alzheimers sufferer. This test could help identify the early stages of Alzheimers disease, and help see if treatments are diminishing this build-up.

There is also Alzheimer research into a skin patch that can be used to administer a drug to help with Alzheimers. Caregivers preferred this patch method to the previously used pill form, and the effects seemed to be better when using the patch. This will continue to be monitored for its effectiveness. Alzheimer research takes many years when looking into new medications and ways to administer it.

Alzheimer research plays an important role in finding ways to not only treat this disease but also, discover it early enough to start treatment. Many scientists and pharmaceutical companies spend much of their time in Alzheimer research.

About Alzheimers

With moral support, things tend to go smoother and its easier to stay focused and remain optimistic.

What is Alzheimers Disease, and Can Anything Be Done About It? Of those 5. This seems to be what triggers early onset Alzheimers. These are generally 23 pairs of chromosomes; one of each pair is received from each parent. In fact, this is because it may not have any one cause at all.

In short, all of the thought cause of alzheimers disease is mostly speculation meaning there is no proof as of yet to scientists theories.
If left alone, they may forget to eat and thus starve to death. For example, if the patient had a parent and/or siblings that were affect by the disease they may be more likely to be affected by it as well. In its earliest stages, a person may suffer memory lapses or behavioral changes so subtle that not even close family members will probably recognize them. Reading e-books and reports that online support groups offer is a big start. - An estimated 5. You may see his temper flare as tasks and conversations become somewhat more challenging.

The doctor will also generally want to know the patients medical history and that of their close relatives.
One class of drugs in the Alzheimers treatment plan is mad to help with the memory function of the brain. Alzheimer disease is a very well known disease that is on the forefront of research. Another drug that is used in an Alzheimers treatment plan is a drug to maintain levels of glutoamate in the brain.